BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29861862)

  • 1. Automated DNA extraction using cellulose magnetic beads can improve
    Nakashima C; Sato A; Abe T; Kato J; Hirai M; Nakamura T; Komiya K; Sueoka E; Kimura S; Sueoka-Aragane N
    Oncotarget; 2018 May; 9(38):25181-25192. PubMed ID: 29861862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.
    Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Abe T; Ureshino N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
    J Thorac Oncol; 2011 Oct; 6(10):1639-48. PubMed ID: 21921847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
    Li Y; Xu H; Su S; Ye J; Chen J; Jin X; Lin Q; Zhang D; Ye C; Chen C
    PLoS One; 2017; 12(8):e0183331. PubMed ID: 28829813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.
    Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Kobayashi N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
    J Thorac Oncol; 2012 Sep; 7(9):1369-81. PubMed ID: 22858585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
    Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X
    J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
    Ma M; Shi C; Qian J; Teng J; Zhong H; Han B
    Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy.
    Sato A; Nakashima C; Abe T; Kato J; Hirai M; Nakamura T; Komiya K; Kimura S; Sueoka E; Sueoka-Aragane N
    Oncotarget; 2018 Aug; 9(61):31904-31914. PubMed ID: 30159131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.
    Sakamoto T; Kodani M; Takata M; Chikumi H; Nakamoto M; Nishii-Ito S; Ueda Y; Izumi H; Makino H; Touge H; Takeda K; Yamasaki A; Yanai M; Tanaka N; Igishi T; Shimizu E
    Int J Oncol; 2015 Apr; 46(4):1473-80. PubMed ID: 25651992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
    Takahama T; Sakai K; Takeda M; Azuma K; Hida T; Hirabayashi M; Oguri T; Tanaka H; Ebi N; Sawa T; Bessho A; Tachihara M; Akamatsu H; Bandoh S; Himeji D; Ohira T; Shimokawa M; Nakanishi Y; Nakagawa K; Nishio K
    Oncotarget; 2016 Sep; 7(36):58492-58499. PubMed ID: 27542267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of EGFR oncogenic mutations in matching tissue and plasma samples from patients with advanced non-small cell lung carcinoma.
    Chai X; Ren P; Wei B; Ma J; Mai L; Cram DS; Song Y; Guo Y
    Clin Chim Acta; 2016 Jun; 457():106-11. PubMed ID: 27071701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of
    Kloten V; Rüchel N; Brüchle NO; Gasthaus J; Freudenmacher N; Steib F; Mijnes J; Eschenbruch J; Binnebösel M; Knüchel R; Dahl E
    Oncotarget; 2017 Oct; 8(49):86253-86263. PubMed ID: 29156792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
    Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ
    Respiration; 2013; 85(2):119-25. PubMed ID: 22797485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
    Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
    JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).
    Lee JY; Qing X; Xiumin W; Yali B; Chi S; Bak SH; Lee HY; Sun JM; Lee SH; Ahn JS; Cho EK; Kim DW; Kim HR; Min YJ; Jung SH; Park K; Mao M; Ahn MJ
    Oncotarget; 2016 Feb; 7(6):6984-93. PubMed ID: 26755650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma.
    Reckamp KL; Melnikova VO; Karlovich C; Sequist LV; Camidge DR; Wakelee H; Perol M; Oxnard GR; Kosco K; Croucher P; Samuelsz E; Vibat CR; Guerrero S; Geis J; Berz D; Mann E; Matheny S; Rolfe L; Raponi M; Erlander MG; Gadgeel S
    J Thorac Oncol; 2016 Oct; 11(10):1690-700. PubMed ID: 27468937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.
    Park S; Hur JY; Lee KY; Lee JC; Rho JK; Shin SH; Choi CM
    Clin Chem Lab Med; 2017 Aug; 55(10):1489-1495. PubMed ID: 28195541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Suzawa K; Yamamoto H; Ohashi K; Hashida S; Tomida S; Kubo T; Maki Y; Soh J; Tsukuda K; Kiura K; Miyoshi S; Toyooka S
    Oncol Rep; 2017 May; 37(5):3100-3106. PubMed ID: 28405680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of EGFR gene somatic mutations in tissues and plasma of patients with advanced non-small cell lung cancer].
    Brovkina OI; Gordiev MG; Toropovskiy AN; Khodyrev DS; Enikeev RF; Gusev OA; Shigapova LH; Nikitin AG
    Biomed Khim; 2016 Nov; 62(6):638-644. PubMed ID: 28026806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.